{"title":"病理抗体组合","description":"\u003cp\u003e依据组合内真实靶点、成员数量、检测方法、通道与兼容性资料选择病理抗体组合。单独抗体共同列出不等于已验证组合；多重染色、样本种属、组织处理、平台及用途以该组合的技术资料为准。本系列尚未录入产品，可提交研究目标与实验条件咨询。\u003c\/p\u003e","products":[],"url":"https:\/\/bioincn.com\/zh\/collections\/ihc-and-pathology-antibodies-pathology-antibody-panels.oembed","provider":"BioInChina","version":"1.0","type":"link"}